Dudediligence.

Trevi Therapeutics, Inc

TRVINASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$13.2MSep ’24−$11.4MDec ’24−$10.3MMar ’25−$12.3MJun ’25−$11.8MSep ’25−$8.3MDec ’25−$13.2MMar ’26−$17.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$32.5M−$29.9M−$33.9M−$51.5M−$49.3M
Net income−$33.9M−$29.2M−$29.1M−$47.9M−$42.8M
Operating cash flow−$28.9M−$28.2M−$31.7M−$38.3M−$42.1M
Free cash flownone on file−$28.3M−$31.8M−$38.3M−$42.1M
Cash$36.8M$12.6M$32.4M$34.1M$18.9M
Shares outstanding28.5M59.9M68.3M93.6M128.3M